Incidence of SARS-COV-2 infection in sickle cell patients presenting with a painful crisis: A 12-month prospective cohort study.

Konté, Kadère; Nur, Erfan; Tang, Man Wai; Heijmans, Jarom; van Tuijn, Charlotte F J; Biemond, Bart J

Konté, Kadère; Nur, Erfan; Tang, Man Wai; Heijmans, Jarom; van Tuijn, Charlotte F J; Biemond, Bart J.

Konté K; Department of Clinical Haematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Nur E; Department of Clinical Haematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Tang MW; Department of Clinical Haematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Heijmans J; Department of Clinical Haematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
van Tuijn CFJ; Department of Clinical Haematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Biemond BJ; Department of Clinical Haematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Int J Lab Hematol ; 44(2): e87-e90, 2022 04.

Article in English | MEDLINE | ID: covidwho-1470430

Subject(s)

Anemia, Sickle Cell; COVID-19; Anemia, Sickle Cell/complications; Anemia, Sickle Cell/epidemiology; COVID-19/epidemiology; Humans; Incidence; Prospective Studies; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; incidence; sickle cell disease; vaso-occlusive crisis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Anemia, Sickle Cell Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Int J Lab Hematol Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: Ijlh.13739

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google